Related references
Note: Only part of the references are listed.A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia
Jeffrey A. Lieberman et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Clinical Trials of Potential Cognitive-Enhancing Drugs in Schizophrenia: What Have We Learned So Far?
Richard S. E. Keefe et al.
SCHIZOPHRENIA BULLETIN (2013)
α7 Nicotinic receptor modulators for cognitive deficits in schizophrenia and Alzheimer's disease
Hugo Geerts
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors
Jos Prickaerts et al.
NEUROPHARMACOLOGY (2012)
Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia
Daniel C. Javitt et al.
SCHIZOPHRENIA RESEARCH (2012)
A Randomized Clinical Trial of MK-0777 for the Treatment of Cognitive Impairments in People with Schizophrenia
Robert W. Buchanan et al.
BIOLOGICAL PSYCHIATRY (2011)
Alpha7 Neuronal Nicotinic Receptors as Targets for Novel Therapies to Treat Multiple Domains of Schizophrenia
Aaron J. Kucinski et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
RG3487, a Novel Nicotinic alpha 7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents
Tanya L. Wallace et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia
Jean-Pierre Lindenmayer et al.
SCHIZOPHRENIA RESEARCH (2011)
Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial
Richard S. E. Keefe et al.
SCHIZOPHRENIA RESEARCH (2011)
A STUDY COMPARING THE MATRICS BATTERY WITH THE CDR SYSTEM IN SHIZOPHRENIA
Keith Wesnes et al.
SCHIZOPHRENIA RESEARCH (2010)
Dissociating β-Amyloid from α7 Nicotinic Acetylcholine Receptor by a Novel Therapeutic Agent, S 24795, Normalizes α7 Nicotinic Acetylcholine and NMDA Receptor Function in Alzheimer's Disease Brain
Hoau-Yan Wang et al.
JOURNAL OF NEUROSCIENCE (2009)
Initial phase 2 trial of a nicotinic agonist in schizophrenia
Robert Freedman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
The MATRICS consensus cognitive battery, part 2: Co-norming and standardization
Robert S. Kern et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
The MATRICS consensus cognitive battery, part 1: Test selection, reliability, and validity
Keith H. Nuechterlein et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Galantamine for the treatment of cognitive impairments in people with schizophrenia
Robert W. Buchanan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Efficacy and safety of donepezil in patients with schizophrenia or Schizoaffective disorder: Significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial
Richard S. E. Keefe et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Molecular targets for treating cognitive dysfunction in schizophrenia
John A. Gray et al.
SCHIZOPHRENIA BULLETIN (2007)
Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia: A double-blind, randomized, placebo-controlled study
Zhang-Jin Zhang et al.
SCHIZOPHRENIA RESEARCH (2006)
N-terminal domains in mouse and human 5-hydroxytryptamine3A receptors confer partial agonist and antagonist properties to benzylidene analogs of anabaseine
Ran Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Proof-of-concept trial of an α7 nicotinic agonist in schizophrenia
Ann Olincy et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Size of treatment effects and their importance to clinical research and practice
Helena Chmura Kraemer et al.
BIOLOGICAL PSYCHIATRY (2006)
A summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial Design for Neurocognitive Drugs for Schizophrenia.
RW Buchanan et al.
SCHIZOPHRENIA BULLETIN (2005)
Neuronal nicotinic receptors: from structure to pathology
C Gotti et al.
PROGRESS IN NEUROBIOLOGY (2004)
UCSD Performance-Based Skills Assessment: Development of a new measure of everyday functioning for severely mentally ill adults
TL Patterson et al.
SCHIZOPHRENIA BULLETIN (2001)
Share Paper
